Advances in colon-targeted nano-drug delivery systems: challenges and solutions

Colorectal cancer statistics, 2014

Siegel, R. L., Desantis, C. E., & Jemal, A. (2014) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21220 · Cited by 2,598

Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues

Lai, S. K., Wang, Y.-Y., & Hanes, J. S. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.002 · Cited by 1,863

Barrier properties of mucus

Cone, R. A. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.008 · Cited by 1,459

Colorectal cancer

Cunningham, D., Atkin, W. S., Lenz, H., Lynch, H. T., Minsky, B. D., Nordlinger, B., & Starling, N. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60353-4 · Cited by 1,447

The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system

Pelaseyed, T., Bergström, J. H., Gustafsson, J. K., Ermund, A., Birchenough, G. M. H., Schütte, A., van der Post, S., Svensson, F., Rodríguez‐Piñeiro, A. M., Nyström, E. E. L., et al. (2014) · Immunological Reviews · doi:10.1111/imr.12182 · Cited by 1,363

Intestinal Inflammation and Cancer

Ullman, T. A., & Itzkowitz, S. H. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.057 · Cited by 1,127

Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer

Zhang, M., Viennois, É., Prasad, M. A., Zhang, Y., Wang, L., Zhang, Z., Han, M. K., Xiao, B., Xu, C., Srinivasan, S., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.018 · Cited by 1,071

Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)

Duchmann, R., Kaiser, I., Hermann, E., Mayet, W.-J., Ewe, K., & BÜSCHENFELDE, K.-H. M. Z. (1995) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb03836.x · Cited by 938

Grape Exosome-like Nanoparticles Induce Intestinal Stem Cells and Protect Mice From DSS-Induced Colitis

Ju, S., Mu, J., Dokland, T., Zhuang, X., Wang, Q., Jiang, H., Xiang, X., Deng, Z., Wang, B., Zhang, L., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.64 · Cited by 889

Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies

Tsilidis, K. K., Kasimis, J. C., López, D. S., Ntzani, E., & Ioannidis, J. P. A. (2015) · BMJ · doi:10.1136/bmj.g7607 · Cited by 885

Environmental Risk Factors for Inflammatory Bowel Diseases: An Umbrella Review of Meta-analyses

Piovani, D., Danese, S., Peyrin‐Biroulet, L., Nikolopoulos, G. K., Lytras, T., & Bonovas, S. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.04.016 · Cited by 837

Role of nanoparticle size, shape and surface chemistry in oral drug delivery

Banerjee, A., Qi, J., Gogoi, R., Wong, J., & Mitragotri, S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.07.051 · Cited by 777

A Dense Poly(Ethylene Glycol) Coating Improves Penetration of Large Polymeric Nanoparticles Within Brain Tissue

Nance, E. A., Woodworth, G. F., Sailor, K. A., Shih, T.-Y., Xu, Q., Swaminathan, G., Xiang, D., Eberhart, C., & Hanes, J. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003594 · Cited by 649

Biocompatibility, biodegradation and biomedical applications of poly(lactic acid)/poly(lactic-co-glycolic acid) micro and nanoparticles

Elmowafy, E. M., Tiboni, M., & Soliman, M. E. (2019) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-019-00439-x · Cited by 642

Obesity and Risk of Colorectal Cancer: A Systematic Review of Prospective Studies

Ma, Y., Yang, Y., Wang, F., Zhang, P., Shi, C., Zou, Y., & Qin, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053916 · Cited by 622

Composition and functional role of the mucus layers in the intestine

Johansson, M., Ambort, D., Pelaseyed, T., Schutte, A. H., Gustafsson, J. K., Ermund, A., Subramani, D. B., Holmén‐Larsson, J., Thomsson, K. A., Bergström, J. H., et al. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0822-3 · Cited by 594

Geographical variability and environmental risk factors in inflammatory bowel disease

Ng, S. C., Bernstein, C. N., Vatn, M. H., Lakatos, P. L., Loftus, E. V., Tysk, C., O'Morain, C. A., Moum, B. A., & Colombel, J. (2013) · Gut · doi:10.1136/gutjnl-2012-303661 · Cited by 593

Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis

Kane, S. V., Huo, D., Aikens, J. E., & Hanauer, S. B. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01383-9 · Cited by 568

Delivery of therapeutic agents by nanoparticles made of grapefruit-derived lipids

Wang, Q., Zhuang, X., Mu, J., Deng, Z., Jiang, H., Zhang, L., Xiang, X., Wang, B., Yan, J., Miller, D., et al. (2013) · Nature Communications · doi:10.1038/ncomms2886 · Cited by 528

Size-Dependent Bioadhesion of Micro- and Nanoparticulate Carriers to the Inflamed Colonic Mucosa

Lamprecht, A., Schäfer, U., & Lehr, C.-M. (2001) · Pharmaceutical Research · doi:10.1023/a:1011032328064 · Cited by 507

Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract

Ponchel, G. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00040-4 · Cited by 494

Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: Selective targeting to diseased versus healthy tissue

Hua, S., Marks, E., Schneider, J. J., & Keely, S. (2015) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.02.018 · Cited by 494

Broccoli-Derived Nanoparticle Inhibits Mouse Colitis by Activating Dendritic Cell AMP-Activated Protein Kinase

Deng, Z., Rong, Y., Teng, Y., Mu, J., Zhuang, X., Tseng, M. T., Samykutty, A. K., Zhang, L., Yan, J., Miller, D. M., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.01.025 · Cited by 491

Investigation of pH and Temperature Profiles in the GI Tract of Fasted Human Subjects Using the Intellicap® System

Koziolek, M., Grimm, M. F., Becker, D., Iordanov, V. P., Zou, H., Shimizu, J., Wanke, C., Garbacz, G., & Weitschies, W. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24274 · Cited by 473

Edible Ginger-derived Nano-lipids Loaded with Doxorubicin as a Novel Drug-delivery Approach for Colon Cancer Therapy

Zhang, M., Xiao, B., Wang, H., Han, M. K., Zhang, Z., Viennois, É., Xu, C., & Merlin, D. (2016) · Molecular Therapy · doi:10.1038/mt.2016.159 · Cited by 463

Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier

Tang, B. C., Dawson, M., Lai, S. K., Wang, Y.-Y., Suk, J. S., Yang, M., Zeitlin, P., Boyle, M. P., Fu, J., & Hanes, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905998106 · Cited by 453

Gut instincts: Explorations in intestinal physiology and drug delivery

McConnell, E. L., Fadda, H. M., & Basit, A. W. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.05.012 · Cited by 442

Colon-Targeted Oral Drug Delivery Systems: Design Trends and Approaches

Amidon, S., Brown, J. E., & Dave, V. S. (2015) · AAPS PharmSciTech · doi:10.1208/s12249-015-0350-9 · Cited by 423

Nanomedicines: current status and future perspectives in aspect of drug delivery and pharmacokinetics

Choi, Y. H., & Han, H. (2017) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-017-0370-4 · Cited by 408

Innate immune mechanisms of colitis and colitis-associated colorectal cancer

Saleh, M., & Trinchieri, G. (2010) · Nature reviews. Immunology · doi:10.1038/nri2891 · Cited by 406

Review article: the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases

Piechota-Polańczyk, A., & Fichna, J. (2014) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-014-0985-1 · Cited by 396

The Multifaceted Role of the Intestinal Microbiota in Colon Cancer

Irrazábal, T., Belcheva, A., Girardin, S. E., Martín, A., & Philpott, D. J. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.039 · Cited by 361

Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease

Simmonds, N. J., Allen, R. E., Stevens, T., NIALL, R., Someren, M. V., Blake, D. R., & Rampton, D. S. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91112-h · Cited by 356

Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer

Li, L., Ahmed, B., Mehta, K., & Kurzrock, R. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0556 · Cited by 332

Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse

Maisel, K., Ensign, L. M., Reddy, M., Cone, R. A., & Hanes, J. S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.10.026 · Cited by 329

Oral Administration of ginger-derived Nanolipids Loaded With siRNA As a Novel Approach for Efficient siRNA Drug Delivery to Treat Ulcerative Colitis

Zhang, M., Wang, X., Han, M. K., Collins, J. F., & Merlin, D. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0196 · Cited by 319

An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease

Talley, N. J., Abreu, M. T., Achkar, J., Bernstein, C. N., Dubinsky, M. C., Hanauer, S. B., Kane, S. V., Sandborn, W. J., Ullman, T. A., & Moayyedi, P. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.58 · Cited by 316

Characterization of Particle Translocation through Mucin Hydrogels

Lieleg, O., Vladescu, I. D., & Ribbeck, K. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2010.01.012 · Cited by 307

Barrier Properties of Gastrointestinal Mucus to Nanoparticle Transport

Crater, J. S., & Carrier, R. L. (2010) · Macromolecular Bioscience · doi:10.1002/mabi.201000137 · Cited by 303

Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared

Rhodes, J. M., & Campbell, B. J. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02194-3 · Cited by 299

Environmental risk factors for inflammatory bowel disease.

Molodecky, N. A., & Kaplan, G. G. (2010) · PubMed Central · Cited by 289

Drug delivery strategies in the therapy of inflammatory bowel disease

Lautenschläger, C., Schmidt, C., Fischer, D., & Stallmach, A. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.10.001 · Cited by 287

Enteric-coated capsules filled with freeze-dried chitosan/poly(γ-glutamic acid) nanoparticles for oral insulin delivery

Sonaje, K., Chen, Y., Chen, H., Wey, S., Juang, J., Nguyen, H.-N., Hsu, C., Lin, K., & Sung, H. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.042 · Cited by 282

Gut Fermentation of Dietary Fibres: Physico-Chemistry of Plant Cell Walls and Implications for Health

Williams, B. A., Grant, L. J., Gidley, M. J., & Mikkelsen, D. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102203 · Cited by 269

Nano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosa

Collnot, E.-M., Ali, H., & Lehr, C. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.028 · Cited by 253

Bioresponsive drug delivery systems in intestinal inflammation: State-of-the-art and future perspectives

Kotla, N. G., Rana, S., Sivaraman, G., Sunnapu, O., Vemula, P. K., Pandit, A. S., & Rochev, Y. A. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.06.021 · Cited by 248

An in vitro investigation into the suitability of pH-dependent polymers for colonic targeting

Ashford, M. B., Fell, J. T., Attwood, D., & Woodhead, P. J. (1993) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(93)90344-f · Cited by 239

A superoxide dismutase/catalase mimetic nanomedicine for targeted therapy of inflammatory bowel disease

Zhang, Q., Tao, H., Lin, Y., Hu, Y., An, H., Zhang, D., Feng, S., Hu, H., Wang, R., Li, X., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.08.010 · Cited by 236

Very low intraluminal colonic pH in patients with active ulcerative colitis

Fallingborg, J., Christensen, L. A., Jacobsen, B. A., & Rasmussen, S. N. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01297074 · Cited by 227

N-Trimethyl Chitosan Chloride-Coated PLGA Nanoparticles Overcoming Multiple Barriers to Oral Insulin Absorption

Sheng, J., Han, L., Qin, J., Ru, G., Li, R., Wu, L., Cui, D., Yang, P., He, Y., & Wang, J. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b03555 · Cited by 222

Nanoparticle-Based Oral Drug Delivery Systems Targeting the Colon for Treatment of Ulcerative Colitis

Zhang, M., & Merlin, D. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy123 · Cited by 220

Strategies for targeted drug delivery in treatment of colon cancer: Current trends and future perspectives

Banerjee, A., Pathak, S., Subramanium, V. D., G., D., Murugesan, R., & Verma, R. S. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.05.006 · Cited by 204

Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives

Yang, C., & Merlin, D. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s210315 · Cited by 198

An Orally Administered Redox Nanoparticle That Accumulates in the Colonic Mucosa and Reduces Colitis in Mice

Vong, L. B., Tomita, T., Yoshitomi, T., Matsui, H., & Nagasaki, Y. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.043 · Cited by 196

pH-Sensitive nanospheres for colon-specific drug delivery in experimentally induced colitis rat model

Makhlof, A., Tozuka, Y., & Takeuchi, H. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.12.013 · Cited by 192

Optimization of 5-fluorouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer

Yassin, A. E. B., Anwer, M. K., Mowafy, H. A., Elbagory, I., Bayomi, M. A., & Alsarra, I. A. (2010) · International Journal of Medical Sciences · doi:10.7150/ijms.7.398 · Cited by 188

Nanoparticles Enhance Therapeutic Efficiency by Selectively Increased Local Drug Dose in Experimental Colitis in Rats

Lamprecht, A., Yamamoto, H., Takeuchi, H., & Kawashimà, Y. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.088146 · Cited by 186

Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis

Xiao, B., Xu, Z., Viennois, É., Zhang, Y., Zhang, Z., Zhang, M., Han, M. K., Kang, Y., & Merlin, D. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2016.11.020 · Cited by 185

Co-delivery of camptothecin and curcumin by cationic polymeric nanoparticles for synergistic colon cancer combination chemotherapy

Xiao, B., Si, X., Han, M. K., Viennois, É., Zhang, M., & Merlin, D. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb01245g · Cited by 158

Formulation and characterization of 5-Fluorouracil enteric coated nanoparticles for sustained and localized release in treating colorectal cancer

Tummala, S., Kumar, M. N. S., & Prakash, A. (2014) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2014.11.010 · Cited by 152

Budesonide loaded nanoparticles with pH-sensitive coating for improved mucosal targeting in mouse models of inflammatory bowel diseases

Ali, H., Weigmann, B., Neurath, M. F., Collnot, E. M., Windbergs, M., & Lehr, C. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.039 · Cited by 148

Topical delivery of therapeutic agents in the treatment of inflammatory bowel disease

Klotz, U. E., & Schwab, M. G. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.08.007 · Cited by 147

Curcumin Loaded pH-Sensitive Nanoparticles for the Treatment of Colon Cancer

Dandekar, P. P., Ratnesh, J., Chandan, K., Suresh, S., Grace, S. G., Venkatesh, M., & Vandana, P. (2009) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2009.1038 · Cited by 146

An in vivo comparison of intestinal pH and bacteria as physiological trigger mechanisms for colonic targeting in man

McConnell, E. L., Short, M. B., & Basit, A. W. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.022 · Cited by 146

Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease

Xiao, B., & Merlin, D. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.730517 · Cited by 145

The targeting of surface modified silica nanoparticles to inflamed tissue in experimental colitis

Moulari, B., Pertuit, D., Pellequer, Y., & Lamprecht, A. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.08.009 · Cited by 142

Photothermal therapy in a murine colon cancer model using near-infrared absorbing gold nanorods

Goodrich, G. P., Bao, L., Gill‐Sharp, K. L., Sang, K. L., Wang, J., & Payne, J. D. (2010) · Journal of Biomedical Optics · doi:10.1117/1.3290817 · Cited by 140

Advances in orally-delivered pH-sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel disease

Zeeshan, M., Ali, H., Khan, S., Khan, S. A., & Weigmann, B. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.12.074 · Cited by 140

Etiology of inflammatory bowel disease: A unified hypothesis

Qin, X. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i15.1708 · Cited by 139

An in vivo investigation into the suitability of pH dependent polymers for colonic targeting

Ashford, M. B., Fell, J. T., Attwood, D., Sharma, H. L., & Woodhead, P. J. (1993) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(93)90406-6 · Cited by 134

Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double‐blind placebo‐controlled study

Rizzello, F., Gionchetti, P., D’Arienzo, A., Manguso, F., Matteo, G. D., Annese, V., Valpiani, D., Casetti, T., Adamo, S., Prada, A., et al. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01298.x · Cited by 130

5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease

Pertuit, D., Moulari, B., Betz, T., Nadaradjane, A., Neumann, D., Ismaïli, L., Refouvelet, B., Pellequer, Y., & Lamprecht, A. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.08.008 · Cited by 126

Size-controlled biodegradable nanoparticles: Preparation and size-dependent cellular uptake and tumor cell growth inhibition

Choi, J., Cao, J., Naeem, M., Noh, J.-K., Hasan, N., Choi, H., & Yoo, J. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.07.030 · Cited by 125

Colonic gene silencing using siRNA-loaded calcium phosphate/PLGA nanoparticles ameliorates intestinal inflammation in vivo

Frede, A., Neuhaus, B., Klopfleisch, R., Walker, C., Buer, J., Müller, W., Epple, M., & Westendorf, A. M. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.021 · Cited by 119

Alginate/chitosan microparticles for gastric passage and intestinal release of therapeutic protein nanoparticles

Ling, K., Wu, H., Neish, A. S., & Champion, J. A. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.12.017 · Cited by 119

Oral nuclear factor-κB decoy oligonucleotides delivery system with chitosan modified poly(d,l-lactide-co-glycolide) nanospheres for inflammatory bowel disease

Tahara, K., Samura, S., Tsuji, K., Yamamoto, H., Tsukada, Y., Bando, Y., Tsujimoto, H., Morishita, R., & Kawashimà, Y. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.09.034 · Cited by 115

Polymeric nanoparticles for colon cancer therapy: overview and perspectives

You, X., Kang, Y., Hollett, G., Chen, X., Zhao, W., Gu, Z., & Wu, J. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb01925k · Cited by 114

Colon-targeted delivery of cyclosporine A using dual-functional Eudragit® FS30D/PLGA nanoparticles ameliorates murine experimental colitis

Naeem, M., Bae, J., Oshi, M. A., Kim, M., Moon, H. R., Lee, B. L., Im, E., Jung, Y., & Yoo, J. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s157566 · Cited by 113

Colon-targeted delivery of budesonide using dual pH- and time-dependent polymeric nanoparticles for colitis therapy

Yoo, J., Naeem, M., Choi, M., Cao, J., Yoon, S., Kim, M., Jung, Y., Lee, J., Moon, H. R., Ikram, M., et al. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s88672 · Cited by 108

Limited exposure of the healthy distal colon to orally‐dosed formulation is further exaggerated in active left‐sided ulcerative colitis

Hebden, BLACKSHAW, Perkins, Wilson, & Spiller, R. E. (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00697.x · Cited by 107

A comparative study of curcumin-loaded lipid-based nanocarriers in the treatment of inflammatory bowel disease

Beloqui, A., Memvanga, P. B., Coco, R., Reimóndez-Troitiño, S., Alhouayek, M., Muccioli, G. G., Alonso, M. J., Csaba, N., de la Fuente, M., & Véronique Préat, A. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.03.038 · Cited by 105

Unique insights into the intestinal absorption, transit, and subsequent biodistribution of polymer-derived microspheres

Reineke, J., Cho, D., Dingle, Y. L., Morello, A. P., Jacob, J. S., Thanos, C. G., & Mathiowitz, E. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305882110 · Cited by 104

Peptides as drug delivery vehicles across biological barriers

Ghosh, D., Peng, X., Leal, J., & Mohanty, R. P. (2018) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-017-0374-0 · Cited by 102

Development of an oral nanotherapeutics using redox nanoparticles for treatment of colitis-associated colon cancer

Vong, L. B., Yoshitomi, T., Matsui, H., & Nagasaki, Y. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.03.037 · Cited by 100

Probing the interaction of nanoparticles with mucin for drug delivery applications using dynamic light scattering

Griffiths, P. C., Cattoz, B., Ibrahim, M. S., & Anuonye, J. C. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.05.004 · Cited by 97

Polysaccharide-based micro/nanocarriers for oral colon-targeted drug delivery

Zhang, L., Sang, Y., Feng, J., Li, Z., & Zhao, A. (2016) · Journal of drug targeting · doi:10.3109/1061186x.2015.1128941 · Cited by 95

Polymeric nanomedicines for poorly soluble drugs in oral delivery systems: an update

Ma, X., & Williams, R. O. (2017) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-017-0372-2 · Cited by 95

Understanding the colon cancer stem cells and perspectives on treatment

Garza-Treviño, E. N., Said‐Fernández, S., & Martı́nez-Rodrı́guez, H. G. (2015) · Cancer Cell International · doi:10.1186/s12935-015-0163-7 · Cited by 93

Colon-targeted dexamethasone microcrystals with pH-sensitive chitosan/alginate/Eudragit S multilayers for the treatment of inflammatory bowel disease

Oshi, M. A., Naeem, M., Bae, J., Kim, J., Lee, J., Hasan, N., Kim, W., Im, E., Jung, Y., & Yoo, J. (2018) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2018.06.107 · Cited by 93

pH-Sensitive Nanoparticles of Curcumin–Celecoxib Combination: Evaluating Drug Synergy in Ulcerative Colitis Model

Gugulothu, D. B., Kulkarni, A., Patravale, V. B., & Dandekar, P. P. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23828 · Cited by 91

Orally delivered polycurcumin responsive to bacterial reduction for targeted therapy of inflammatory bowel disease

Qiao, H., Fang, D., Chen, J., Sun, Y., Chen, K., Di, L., Li, J., Chen, Z., Chen, J., & Gao, Y. (2017) · Drug Delivery · doi:10.1080/10717544.2016.1245367 · Cited by 84

Oral drug delivery research in Europe

Mrsny, R. J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.017 · Cited by 82

Solid lipid nanoparticles delivering anti-inflammatory drugs to treat inflammatory bowel disease: Effects in anin vivomodel

Dianzani, C., Foglietta, F., Ferrara, B., Rosa, A. C., Muntoni, E., Gasco, P., Pepa, C. D., Canaparo, R., & Serpe, L. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i23.4200 · Cited by 81

Recent formulation approaches to oral delivery of herbal medicines

Byeon, J. C., Ahn, J. B., Jang, W. S., Lee, S., Choi, J., & Park, J. (2018) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-018-0394-4 · Cited by 78

Orally administered liposomal formulations for colon targeted drug delivery

Hua, S. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00138 · Cited by 77

Overcoming therapeutic obstacles in inflammatory bowel diseases: A comprehensive review on novel drug delivery strategies

Talaei, F., Atyabi, F., Azhdarzadeh, M., Dinarvand, R., & Saadatzadeh, A. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.04.031 · Cited by 77

The use of pharmacoscintigraphy to focus the development strategy for a novel 5-ASA colon targeting system (“TIME CLOCK®” system)

Steed, K. P., Hooper, G., Monti, N. C., Benedetti, M. S., Fornasini, G., & Wilding, I. R. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00062-x · Cited by 69

Chitosan-zein nano-in-microparticles capable of mediating in vivo transgene expression following oral delivery

Farris, E., Brown, D. M., Ramer‐Tait, A. E., & Pannier, A. K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.035 · Cited by 69

Nanoparticle-based clodronate delivery mitigates murine experimental colitis

Niebel, W., Walkenbach, K., Béduneau, A., Pellequer, Y., & Lamprecht, A. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.004 · Cited by 68

Therapeutic effect of gold nanoparticles on DSS-induced ulcerative colitis in mice with reference to interleukin-17 expression

Abdelmegid, A. M., Abdo, F. K., Ahmed, F. E., & Kattaia, A. A. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-46671-1 · Cited by 68

Specific accumulation of orally administered redox nanotherapeutics in the inflamed colon reducing inflammation with dose–response efficacy

Vong, L. B., Mo, J., Abrahamsson, B., & Nagasaki, Y. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.05.275 · Cited by 67

Treating inflammatory bowel disease by adsorptive leucocytapheresis: A desire to treat without drugs

Saniabadi, A. R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i29.9699 · Cited by 67

Development of genistein-PEGylated silica hybrid nanomaterials with enhanced antioxidant and antiproliferative properties on HT29 human colon cancer cells.

Pool, H., Campos-Vega, R., Herrera-Hernández, M. G., García‐Solís, P., García-Gasca, T., Sánchez, I. C., Luna‐Bárcenas, G., & Vergara‐Castañeda, H. A. (2018) · Europe PMC (PubMed Central) · Cited by 66

Objective evaluation of small bowel and colonic transit time using pH telemetry in athletes with gastrointestinal symptoms

Rao, K. A., Yazaki, E., Evans, D. F., & Carbon, R. (2004) · British Journal of Sports Medicine · doi:10.1136/bjsm.2003.006825 · Cited by 64

Nanotechnologies for the treatment of colon cancer: From old drugs to new hope

Kotelevets, L., Chastre, E., Desmaële, D., & Couvreur, P. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.06.005 · Cited by 64

Biodistribution and targeting potential assessment of mucoadhesive chitosan nanoparticles designed for ulcerative colitis via scintigraphy

Raj, R., Raj, R., Kaul, A., Mishra, A. K., & Ram, A. (2018) · RSC Advances · doi:10.1039/c8ra01898g · Cited by 64

Production of nanoparticles-in-microparticles by a double emulsion method: A comprehensive study

Lee, Y.-S., Johnson, P. J., Robbins, P. T., & Bridson, R. H. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.10.016 · Cited by 63

pH-triggered surface charge-reversal nanoparticles alleviate experimental murine colitis via selective accumulation in inflamed colon regions

Naeem, M., Oshi, M. A., Kim, J., Lee, J., Cao, J., Hasan, N., Im, E., Jung, Y., & Yoo, J. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.01.003 · Cited by 62

Aptamer-Conjugated Apigenin Nanoparticles To Target Colorectal Carcinoma: A Promising Safe Alternative of Colorectal Cancer Chemotherapy

Dutta, D., Chakraborty, A., Mukherjee, B., & Gupta, S. (2018) · ACS Applied Bio Materials · doi:10.1021/acsabm.8b00441 · Cited by 62

Nanoparticle-in-microparticle oral drug delivery system of a clinically relevant darunavir/ritonavir antiretroviral combination

Augustine, R., Ashkenazi, D. L., Arzi, R. S., Zlobin, V., Shofti, R., & Sosnik, A. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.04.045 · Cited by 61

Anti-inflammatory effects of sinapic acid on 2,4,6-trinitrobenzenesulfonic acid-induced colitis in mice

Lee, J.-Y. (2018) · Archives of Pharmacal Research · doi:10.1007/s12272-018-1006-6 · Cited by 60

In vitroevaluation and pharmacokinetics in dogs of guar gum and Eudragit FS30D-coated colon-targeted pellets of indomethacin

Ji, C., Xu, H., & Wu, W. (2007) · Journal of drug targeting · doi:10.1080/10611860601143727 · Cited by 59

Adherence in ulcerative colitis: an overview

Testa, A., Castiglione, F., Nardone, O. M., & Colombo, G. L. (2017) · Patient Preference and Adherence · doi:10.2147/ppa.s127039 · Cited by 59

Pharmaceutical and pharmacokinetic evaluation of novel rectal mucoadhesive hydrogels containing tolmetin sodium

Ramadan, A. A., Elbakry, A. M., Esmaeil, A. H., & Khaleel, S. A. (2017) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-017-0365-1 · Cited by 59

Positively Charged Surface-Modified Solid Lipid Nanoparticles Promote the Intestinal Transport of Docetaxel through Multifunctional Mechanisms in Rats

Shi, L., Xie, H., Lu, J. E., Cao, Y. Z., Liu, J.-Y., Zhang, X., Zhang, H., Cui, J.-H., & Cao, Q. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00226 · Cited by 58

The in vivo fate of nanoparticles and nanoparticle-loaded microcapsules after oral administration in mice: Evaluation of their potential for colon-specific delivery

Ma, Y., Fuchs, A. V., Boase, N. R. B., Rolfe, B. E., Coombes, A. G. A., & Thurecht, K. J. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.06.014 · Cited by 55

Formulation and development of release modulated colon targeted system of meloxicam for potential application in the prophylaxis of colorectal cancer

Patel, M. M., & Amin, A. F. (2010) · Drug Delivery · doi:10.3109/10717544.2010.538447 · Cited by 53

Liposomes coated with N-trimethyl chitosan to improve the absorption of harmine in vivo and in vitro

Zhang, X., Chen, W., Yuan, Z.-Q., Liu, Y., Yang, S.-D., Zhang, C.-G., Li, J., Zhu, W.-J., Li, F., Zhou, X., et al. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s95540 · Cited by 53

Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications

Ruttala, H. B., Ramasamy, T., Madeshwaran, T., Tran, T. H., Umadevi, K., Oh, K. T., Choi, H., Yong, C. S., & Kim, J. O. (2017) · Archives of Pharmacal Research · doi:10.1007/s12272-017-0995-x · Cited by 52

5-Fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer

Prados, J., Ortíz, Melguizo, Arias, J. L., Ruíz, Álvarez, Caba, O., Luque, Segura, & Aránega (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s26401 · Cited by 48

Recent advances in orally administered cell-specific nanotherapeutics for inflammatory bowel disease

Si, X., Merlin, D., & Xiao, B. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i34.7718 · Cited by 48

Nanomedicines for oral administration based on diverse nanoplatform

Sim, T., Lim, C., Hoang, N. H., Joo, H., Lee, J., Kim, D.-W., Lee, E. S., Youn, Y. S., Kim, J. O., & Oh, K. T. (2016) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-016-0255-y · Cited by 46

Targeted delivery of Cyclosporine A by polymeric nanocarriers improves the therapy of inflammatory bowel disease in a relevant mouse model

Melero, A., Draheim, C., Hansen, S., Giner, E., Carreras, J. J., Taléns‐Visconti, R., Garrigues, T., Peris, J., Recio, M. C., Giner, R. M., et al. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.07.004 · Cited by 44

Application of a Biomagnetic Measurement System (BMS) to the Evaluation of Gastrointestinal Transit of Intestinal Pressure-Controlled Colon Delivery Capsules (PCDCs) in Human Subjects

Hu, Z., Mawatari, S., Shibata, N., Takada, K., Yoshikawa, H., Arakawa, A., & Yosida, Y. (2000) · Pharmaceutical Research · doi:10.1023/a:1007561129221 · Cited by 39

Enhanced therapeutic efficacy of budesonide in experimental colitis with enzyme/pH dual-sensitive polymeric nanoparticles

Yoo, J., Naeem, M., Cao, J., Choi, M., Kim, W., Moon, H. R., Lee, B. L., Kim, M., & Jung, Y. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s87816 · Cited by 39

Liposomal Formulations of Inflammatory Bowel Disease Drugs: Local versus Systemic Drug Delivery in a Rat Model

Kesisoglou, F., Zhou, S. Y., Niemiec, S. M., Lee, J. W., Zimmermann, E. M., & Fleisher, D. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-5376-3 · Cited by 37

Preparation, characterization, and pharmacokinetics of liposomal docetaxel for oral administration

Kim, J. H., Shin, D. H., & Kim, J.-S. (2018) · Archives of Pharmacal Research · doi:10.1007/s12272-018-1046-y · Cited by 37

Potential functional applications of extracellular vesicles: a report by the NIH Common Fund Extracellular RNA Communication Consortium

Quesenberry, P. J., Aliotta, J. M., Camussi, G., Abdel‐Mageed, A. B., Wen, S., Goldberg, L. R., Zhang, H., Tetta, C., Franklin, J. L., Coffey, R. J., et al. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.27575 · Cited by 36

Biopharmaceutical considerations and characterizations in development of colon targeted dosage forms for inflammatory bowel disease

Malayandi, R., Kondamudi, P. K., Ruby, P. K., & Aggarwal, D. (2013) · Drug Delivery and Translational Research · doi:10.1007/s13346-013-0185-4 · Cited by 34

Enhanced photodyamic therapy via photosensitizer-loaded nanoparticles for cancer treatment

Jeon, G., & Ko, Y. T. (2017) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-017-0363-3 · Cited by 32

Natural anti-proliferative agent loaded self-microemulsifying nanoparticles for potential therapy in oral squamous carcinoma

Patil, S. C., Tagalpallewar, A. A., & Kokare, C. (2018) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-018-00415-x · Cited by 32

Effect of food intake on the delivery of fluorescein as a model drug in colon delivery capsule after oral administration to beagle dogs

Matsuda, K., Takaya, T., Shimoji, F., Muraoka, M., Yoshikawa, Y., & Takada, K. (1996) · Journal of drug targeting · doi:10.3109/10611869609046263 · Cited by 26

Nanoparticle-in-Microparticle Delivery Systems (NiMDS): Production, Administration Routes and Clinical Potential

Imperiale, J. C., & Sosnik, A. (2012) · Journal of Biomaterials and Tissue Engineering · doi:10.1166/jbt.2013.1064 · Cited by 21

Application Potential of Polymeric Nanoconstructs for Colon-Specific Drug Delivery

Jain, S., Tiwari, A., Jain, A., Verma, A., Saraf, S., Panda, P. K., & Gour, G. (2018) · Advances in medical technologies and clinical practice book series · doi:10.4018/978-1-5225-4781-5.ch002 · Cited by 20

Physicochemical characterization of naproxen microcrystals for colon specific pulsatile drug delivery designed using pulsincap technique

Thapaliya, R., Shrestha, K., Sharma, A., Dhakal, N., Manandhar, P., Shrestha, S., & Bhattarai, R. (2019) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-019-00425-3 · Cited by 18

Colonic delivery of celecoxib is a potential pharmaceutical strategy for repositioning the selective COX-2 inhibitor as an anti-colitic agent

Kim, W., Lee, Y., Jeong, S., Nam, J., Lee, S., & Jung, Y. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0602-y · Cited by 16

Macropored microparticles with a core–shell architecture for oral delivery of biopharmaceuticals

Homayun, B., Kumar, A., Nascimento, P. T. H., & Choi, H. (2018) · Archives of Pharmacal Research · doi:10.1007/s12272-018-1062-y · Cited by 14

Therapeutic Approaches to the Treatment of Ulcerative Colitis

Sandborn, W. J. (2010) · Wiley eBooks · doi:10.1002/9781444318418.ch28 · Cited by 5

Smart drug delivery systems for precise cancer therapy

Wang, X., Li, C., Wang, Y., Chen, H., Zhang, X., Luo, C., Zhou, W., Li, L., Teng, L., Yu, H., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.08.013 · Cited by 256

Application of chitosan/alginate nanoparticle in oral drug delivery systems: prospects and challenges

Li, S., Zhang, H., Chen, K., Jin, M., Vu, S. H., Jung, S., He, N., Zhou, Z. G., & Lee, M. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2058646 · Cited by 221

Mucoadhesive carriers for oral drug delivery

Kumar, R., Islam, T., & Nurunnabi, M. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.09.024 · Cited by 212

Oral delivery of micro/nanoparticulate systems based on natural polysaccharides for intestinal diseases therapy: Challenges, advances and future perspectives

dos Santos, A. M., Carvalho, S. G., Meneguin, A. B., Sábio, R. M., Gremião, M. P. D., & Chorilli, M. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.04.026 · Cited by 178

Current-status and applications of polysaccharides in drug delivery systems

Prasher, P., Sharma, M., Mehta, M., Satija, S., Aljabali, A. A. A., Tambuwala, M. M., Anand, K., Sharma, N., Dureja, H., Jha, N. K., et al. (2021) · Colloids and Interface Science Communications · doi:10.1016/j.colcom.2021.100418 · Cited by 175

Colon targeted drug delivery systems: Based on Polymers

Patel, S., Bhadoria, A. S., & Patani, P. V. (2022) · Journal of Pharmaceutical Negative Results · doi:10.47750/pnr.2022.13.s03.295

Nano based enemas for colon targeting

Sarma, A., Chakraborty, T., Das, B. K., & Goswami, A. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-24806-1.00022-4

Oral Nano-Delivery Systems for Colon Targeting Therapy

Zhang, T., Zhu, G., Lu, B., & Peng, Q. (2017) · Pharmaceutical Nanotechnology · doi:10.2174/2211738505666170424122722 · Cited by 38

Colon Targeted Nano Drug Delivery Systems

Tarannum, H. (2024) · Materials research foundations · doi:10.21741/9781644902998-5 · Cited by 1

A Review On: Colon Targeted Drug Delivery System

Pawar, A. M., Patil, S. R., & Fegade, T. D. (2020) · American Journal of PharmTech Research · doi:10.46624/ajptr.2020.v10.i2.016 · Cited by 8